493 related articles for article (PubMed ID: 28495456)
21. Prolactin and epidermal growth factor stimulate adipophilin synthesis in HC11 mouse mammary epithelial cells via the PI3-kinase/Akt/mTOR pathway.
Pauloin A; Chanat E
Biochim Biophys Acta; 2012 May; 1823(5):987-96. PubMed ID: 22426621
[TBL] [Abstract][Full Text] [Related]
22. Role of Runx2 in crosstalk between Mek/Erk and PI3K/Akt signaling in MCF-10A cells.
Tandon M; Chen Z; Pratap J
J Cell Biochem; 2014 Dec; 115(12):2208-17. PubMed ID: 25147082
[TBL] [Abstract][Full Text] [Related]
23. Proliferation and polarity in breast cancer: untying the Gordian knot.
Liu H; Radisky DC; Bissell MJ
Cell Cycle; 2005 May; 4(5):646-9. PubMed ID: 15846085
[TBL] [Abstract][Full Text] [Related]
24. Regulation of the JAK2-STAT5 Pathway by Signaling Molecules in the Mammary Gland.
Tian M; Qi Y; Zhang X; Wu Z; Chen J; Chen F; Guan W; Zhang S
Front Cell Dev Biol; 2020; 8():604896. PubMed ID: 33282878
[TBL] [Abstract][Full Text] [Related]
25. Estrogen receptor beta growth-inhibitory effects are repressed through activation of MAPK and PI3K signalling in mammary epithelial and breast cancer cells.
Cotrim CZ; Fabris V; Doria ML; Lindberg K; Gustafsson JÅ; Amado F; Lanari C; Helguero LA
Oncogene; 2013 May; 32(19):2390-402. PubMed ID: 22751110
[TBL] [Abstract][Full Text] [Related]
26. Janus kinase 2 is required for the initiation but not maintenance of prolactin-induced mammary cancer.
Sakamoto K; Triplett AA; Schuler LA; Wagner KU
Oncogene; 2010 Sep; 29(39):5359-69. PubMed ID: 20639901
[TBL] [Abstract][Full Text] [Related]
27. An integrated genomic approach identifies that the PI3K/AKT/FOXO pathway is involved in breast cancer tumor initiation.
Smit L; Berns K; Spence K; Ryder WD; Zeps N; Madiredjo M; Beijersbergen R; Bernards R; Clarke RB
Oncotarget; 2016 Jan; 7(3):2596-610. PubMed ID: 26595803
[TBL] [Abstract][Full Text] [Related]
28. Coactivation of janus tyrosine kinase (Jak)1 positively modulates prolactin-Jak2 signaling in breast cancer: recruitment of ERK and signal transducer and activator of transcription (Stat)3 and enhancement of Akt and Stat5a/b pathways.
Neilson LM; Zhu J; Xie J; Malabarba MG; Sakamoto K; Wagner KU; Kirken RA; Rui H
Mol Endocrinol; 2007 Sep; 21(9):2218-32. PubMed ID: 17550976
[TBL] [Abstract][Full Text] [Related]
29. JAK kinases overexpression promotes in vitro cell transformation.
Knoops L; Hornakova T; Royer Y; Constantinescu SN; Renauld JC
Oncogene; 2008 Mar; 27(11):1511-9. PubMed ID: 17873904
[TBL] [Abstract][Full Text] [Related]
30. Cyclophilin A Function in Mammary Epithelium Impacts Jak2/Stat5 Signaling, Morphogenesis, Differentiation, and Tumorigenesis in the Mammary Gland.
Volker SE; Hedrick SE; Feeney YB; Clevenger CV
Cancer Res; 2018 Jul; 78(14):3877-3887. PubMed ID: 29959151
[TBL] [Abstract][Full Text] [Related]
31. Controlled synchronization of prolactin/STAT5 and AKT1/mTOR in bovine mammary epithelial cells.
Wang B; Shi L; Men J; Li Q; Hou X; Wang C; Zhao F
In Vitro Cell Dev Biol Anim; 2020 Mar; 56(3):243-252. PubMed ID: 32078727
[TBL] [Abstract][Full Text] [Related]
32. Impaired alveologenesis and maintenance of secretory mammary epithelial cells in Jak2 conditional knockout mice.
Wagner KU; Krempler A; Triplett AA; Qi Y; George NM; Zhu J; Rui H
Mol Cell Biol; 2004 Jun; 24(12):5510-20. PubMed ID: 15169911
[TBL] [Abstract][Full Text] [Related]
33. Induction of multidrug resistance transporter ABCG2 by prolactin in human breast cancer cells.
Wu AM; Dalvi P; Lu X; Yang M; Riddick DS; Matthews J; Clevenger CV; Ross DD; Harper PA; Ito S
Mol Pharmacol; 2013 Feb; 83(2):377-88. PubMed ID: 23150485
[TBL] [Abstract][Full Text] [Related]
34. TDAG51 is an ERK signaling target that opposes ERK-mediated HME16C mammary epithelial cell transformation.
Oberst MD; Beberman SJ; Zhao L; Yin JJ; Ward Y; Kelly K
BMC Cancer; 2008 Jul; 8():189. PubMed ID: 18597688
[TBL] [Abstract][Full Text] [Related]
35. Activated STAT5 proteins induce activation of the PI 3-kinase/Akt and Ras/MAPK pathways via the Gab2 scaffolding adapter.
Nyga R; Pecquet C; Harir N; Gu H; Dhennin-Duthille I; Régnier A; Gouilleux-Gruart V; Lassoued K; Gouilleux F
Biochem J; 2005 Aug; 390(Pt 1):359-66. PubMed ID: 15833084
[TBL] [Abstract][Full Text] [Related]
36. Transcriptional activation of signal transducer and activator of transcription (STAT) 3 and STAT5B partially mediate homeobox A1-stimulated oncogenic transformation of the immortalized human mammary epithelial cell.
Mohankumar KM; Perry JK; Kannan N; Kohno K; Gluckman PD; Emerald BS; Lobie PE
Endocrinology; 2008 May; 149(5):2219-29. PubMed ID: 18276758
[TBL] [Abstract][Full Text] [Related]
37. Co-overexpression of Janus kinase 2 and signal transducer and activator of transcription 5a promotes differentiation of mammary cancer cells through reversal of epithelial-mesenchymal transition.
Sultan AS; Brim H; Sherif ZA
Cancer Sci; 2008 Feb; 99(2):272-9. PubMed ID: 18271926
[TBL] [Abstract][Full Text] [Related]
38. Oncogenic Kit controls neoplastic mast cell growth through a Stat5/PI3-kinase signaling cascade.
Harir N; Boudot C; Friedbichler K; Sonneck K; Kondo R; Martin-Lannerée S; Kenner L; Kerenyi M; Yahiaoui S; Gouilleux-Gruart V; Gondry J; Bénit L; Dusanter-Fourt I; Lassoued K; Valent P; Moriggl R; Gouilleux F
Blood; 2008 Sep; 112(6):2463-73. PubMed ID: 18579792
[TBL] [Abstract][Full Text] [Related]
39. Key signalling nodes in mammary gland development and cancer. Signalling downstream of PI3 kinase in mammary epithelium: a play in 3 Akts.
Wickenden JA; Watson CJ
Breast Cancer Res; 2010; 12(2):202. PubMed ID: 20398329
[TBL] [Abstract][Full Text] [Related]
40. A non-catalytic function of the Src family tyrosine kinases controls prolactin-induced Jak2 signaling.
García-Martínez JM; Calcabrini A; González L; Martín-Forero E; Agulló-Ortuño MT; Simon V; Watkin H; Anderson SM; Roche S; Martín-Pérez J
Cell Signal; 2010 Mar; 22(3):415-26. PubMed ID: 19892015
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]